feed,title,long_url,short_url
Benzinga,Great Elm Capital Corp. Announces Third Quarter 2020 Financial Results Highlighted by Net Investment Income of $0.18 per Share,https://www.benzinga.com/pressreleases/20/11/g18268995/great-elm-capital-corp-announces-third-quarter-2020-financial-results-highlighted-by-net-investmen,https://j.mp/3eH8N67
Benzinga,"CONCERNED SHAREHOLDERS OF AUSTRALIS highlight exorbitant Compensation Grants, CONFUSING ASSESSMENT and SET SIGHTS ON EXPANDED U.S. CANNABIS OPPORTUNITY",https://www.benzinga.com/pressreleases/20/11/n18268958/concerned-shareholders-of-australis-highlight-exorbitant-compensation-grants-confusing-assessment-,https://j.mp/3n51IPB
Benzinga,Datametica delivers Pelican through the Google Cloud Marketplace,https://www.benzinga.com/pressreleases/20/11/n18268888/datametica-delivers-pelican-through-the-google-cloud-marketplace,https://j.mp/3leBRnU
Benzinga,Orchard Therapeutics to Present at Barclays Gene Editing & Gene Therapy Summit,https://www.benzinga.com/pressreleases/20/11/g18268892/orchard-therapeutics-to-present-at-barclays-gene-editing-gene-therapy-summit,https://j.mp/3n6sqat
Benzinga,"Intercept Pharmaceuticals Reports Third Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update",https://www.benzinga.com/pressreleases/20/11/g18268883/intercept-pharmaceuticals-reports-third-quarter-2020-financial-results-announces-updates-to-financ,https://j.mp/36gMfVL
Benzinga,Great Elm Capital Corp. Declares Quarterly Cash Distribution of $0.10 per Share,https://www.benzinga.com/pressreleases/20/11/g18268877/great-elm-capital-corp-declares-quarterly-cash-distribution-of-0-10-per-share,https://j.mp/3kcd7Ly
Benzinga,Codexis to Participate at Three Virtual Investment Conferences in November,https://www.benzinga.com/pressreleases/20/11/g18268876/codexis-to-participate-at-three-virtual-investment-conferences-in-november,https://j.mp/3n4mv5S
Benzinga,Calithera Biosciences Presents New Preclinical Data for CB-668 at Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting,https://www.benzinga.com/pressreleases/20/11/g18268874/calithera-biosciences-presents-new-preclinical-data-for-cb-668-at-society-for-immunotherapy-of-can,https://j.mp/3eECJQ2
Benzinga,IGM Biosciences to Present at Three Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18268869/igm-biosciences-to-present-at-three-upcoming-investor-conferences,https://j.mp/2U8i2CD
Benzinga,"Trevena, Inc. to Participate in the Following November Virtual Investor Conferences",https://www.benzinga.com/pressreleases/20/11/g18268866/trevena-inc-to-participate-in-the-following-november-virtual-investor-conferences,https://j.mp/36gMgsN
Benzinga,Plug Power Announces 2020 Third Quarter Results,https://www.benzinga.com/pressreleases/20/11/g18268865/plug-power-announces-2020-third-quarter-results,https://j.mp/38r2oKU
Benzinga,Nanox Announces Third Quarter 2020 Results and Provides Business Update,https://www.benzinga.com/pressreleases/20/11/g18268864/nanox-announces-third-quarter-2020-results-and-provides-business-update,https://j.mp/38rUMbk
Benzinga,"Mitek to Participate in the Benchmark Company Technology Virtual 1x1 Investor Conference on November 12, 2020",https://www.benzinga.com/pressreleases/20/11/g18268859/mitek-to-participate-in-the-benchmark-company-technology-virtual-1x1-investor-conference-on-novemb,https://j.mp/3kaNpXJ
Benzinga,Nurix Therapeutics to Present at Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18268858/nurix-therapeutics-to-present-at-upcoming-investor-conferences,https://j.mp/2IgrOAb
